Prof. Dr. Markus Neurath

Lehrstuhl für Innere Medizin I (Medizin 1)

Safety and tolerability of a single infusion of autologous ex vivo expanded regulatory T cells in adults with ulcerative colitis (ER-TREG 01): protocol of a phase 1, open-label, fast-track dose-escalation clinical trial (2021) Voskens C, Stoica D, Roessner S, Vitali F, Zundler S, Rosenberg M, Wiesinger M, et al. Journal article Cross-sectional imaging of intestinal barrier dysfunction by confocal laser endomicroscopy can identify patients with food allergy in vivo with high sensitivity (2021) Rath T, Dieterich W, Kätscher-Murad C, Neurath M, Zopf Y Journal article Effects of very low volume high intensity versus moderate intensity interval training in obese metabolic syndrome patients: a randomized controlled study (2021) Reljic D, Frenk F, Herrmann HJ, Neurath M, Zopf Y Journal article Clinical experiences and predictors of success of treatment with vedolizumab in IBD patients: a cohort study (2021) Mühl L, Becker E, Müller T, Atreya R, Atreya I, Neurath M, Zundler S Journal article CRISPR/Cas9 in Gastrointestinal Malignancies (2021) Jefremow A, Neurath M, Waldner M Journal article, Review article Reframing immune-mediated inflammatory diseases (2021) Boutrid N, Rahmoune H, Schett G, McInnes I, Neurath M Journal article α4β7 integrin-dependent adhesion of T cells to MAdCAM-1 is blocked by vedolizumab in patients with chronic refractory pouchitis (2021) Melde M, Müller T, Schneider IHF, Geppert CI, Mühl L, Besendorf L, Allner C, et al. Journal article Drug Therapy in Gastroenterology: Molecular Basis of IBD (2021) Neurath M Journal article, Editorial Autophagy in cancer therapy—molecular mechanisms and current clinical advances (2021) Ganzleben I, Neurath M, Becker C Journal article, Review article A Possible Distinct Molecular Subtype (Quintuple-Wildtype) of Metastatic Colorectal Cancer in First-Line Anti-EGFR Therapy with Cetuximab Plus FOLFIRI - Palliative Precision Therapy and a Multidisciplinary Treatment Approach: Interim Analysis of the IVOPAK II Trial with Early Results (2021) Wein A, Stöhr R, Kersting S, Siebler J, Merkel S, Busse D, Wolff K, et al. Journal article